Tumor necrosis factor region polymorphisms are associated with AIDS and with cytomegalovirus retinitis

AIDS

Volumn 23, Issue 13, 2009, Pages 1641-1647

  Deghaide, Neifi H S ^a   Rodrigues, Maria De L V ^a   Castelli, Erick C ^a   Mendes Jr , Celso T ^a   Figueiredo, José F C ^a   Donadi, Eduardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Cytomegalovirus; Microsatellites; Retinitis; Single nucleotide polymorphisms; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS RETINITIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 69449083060     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832e5591     Document Type: Article

References (31)

1. Belfort R Jr. The ophthalmologist and the global impact of the AIDS epidemic LV Edward Jackson Memorial Lecture. Am J Ophthalmol 2000; 129:1-8.
2. Goldberg DE, Wang H, Azen SP, Freeman WR. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol 2003; 87:853-855. (Pubitemid 36765248)
3. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30:231-233. (Pubitemid 30067103)
4. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989; 96:1092-1099. (Pubitemid 19182156)
5. Jabs DA, Martin BK, Forman MS, Ricks MO. Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis. J Infect Dis 2005; 192:640-649.
6. Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, Hurley L, et al. Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy. AIDS 2004; 18:1503-1511. (Pubitemid 39037474)
7. Price P, Keane NM, Stone SF, Cheong KY, French MA. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol 2001; 62:157-164. (Pubitemid 32171654)
8. Veronese Rodrigues Mde L, de Castro Figueiredo JF, Deghaide NH, Romao E, Vieira de Souza N, Donadi EA. Frequency of HLA class 1 and 2 alleles in Brazilian patients with AIDS and cytomegalovirus retinitis. Acta Ophthalmol Scand 2003; 81:514-516. (Pubitemid 37265673)
9. Veronese Rodrigues Mde L, Demarco ALG, de Castro Figueiredo JF, Deghaide NHS, Romao E, Donadi EA. HLA-B35 antigen is associated to susceptibility to ocular infections in patients with AIDS. Ophthalmic Res 2004; 36:86.
10. Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, et al. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990; 87:782-785. (Pubitemid 20051455)
11. Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJ, Sauerwein HP. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994; 169:739-745. (Pubitemid 24102103)
12. Morlat P, Pereira E, Clayette P, Derreudre-Bosquet N, Ecobichon JL, Benveniste O, et al. Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients. AIDS Res Hum Retroviruses 2008; 24:1383-1389.
13. Mondino BJ, Sidikaro Y, Mayer FJ, Sumner HL. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest Ophthalmol Vis Sci 1990; 31:798-804. (Pubitemid 20186090)
14. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 2000; 50:216-228. (Pubitemid 30610098)
15. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001; 62:1191-1199. (Pubitemid 33032271)
16. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16:180-186.
17. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34:391-399. (Pubitemid 27368335)
18. Prevention CfDCa. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269:729-730.
19. Marsh HP, Haldar NA, Bunce M, Marshall SE, le Monier K, Winsey SL, et al. Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation. Br J Cancer 2003; 89:1096-1101. (Pubitemid 37239218)
20. Tuglular S, Berthoux P, Berthoux F. Polymorphisms of the tumour necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 2003; 18:724-731. (Pubitemid 36432254)
21. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48:361-372.
22. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995; 86:248-249.
23. Raymond M, Rousset F. An exact test for population differentiation. Evolution 1995; 49:1280-1283.
24. Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1:47-50.
25. Excoffier L, Slatkin M. Incorporating genotypes of relatives into a test of linkage disequilibrium. Am J Hum Genet 1998; 62:171-180. (Pubitemid 28093846)
26. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989. (Pubitemid 32289743)
27. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-231. (Pubitemid 23031920)
28. Derkx HHF, Bruin KF, Jongeneel CV, Waal LP, Brinkmam BMN, Verweij CL, et al. Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro: relationship to TNF gene polymorphism. J Endotoxin Res 1995; 2:19-25.
29. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3:263-292. (Pubitemid 35217438)
30. Fernandes AP, Goncalves MA, Zavanella RB, Figueiredo JF, Donadi EA, Rodrigues ML. HLA markers associated with progression to AIDS are also associated with susceptibility to cytomegalovirus retinitis. AIDS 2003; 17:2133-2136.
31. Khoo SH, Pepper L, Snowden N, Hajeer AH, Vallely P, Wilkins EG, et al. Tumour necrosis c2 microsatellite allele is associated with the rate of HIV disease progression factor. AIDS 1997; 11:423-428. (Pubitemid 27113002)